[1] Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet 2016;388(10060):2665 − 712. http://dx.doi.org/10.1016/S0140-6736(16)31134-5CrossRef
[2] Wang ZL, Chen Z, Zhang LF, Wang X, Hao G, Zhang ZG, et al. Status of hypertension in China: results from the China hypertension survey, 2012-2015. Circulation 2018;137(22):2344 − 56. http://dx.doi.org/10.1161/CIRCULATIONAHA.117.032380CrossRef
[3] Li YC, Yang L, Wang LM, Zhang M, Huang ZJ, Deng Q, et al. Burden of hypertension in China: a nationally representative survey of 174,621 adults. Int J Cardiol 2017;227:516 − 23. http://dx.doi.org/10.1016/j.ijcard.2016.10.110CrossRef
[4] Wu YF, Huxley R, Li LM, Anna V, Xie GQ, Yao CH, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China national nutrition and health survey 2002. Circulation 2008;118(25):2679 − 86. http://dx.doi.org/10.1161/CIRCULATIONAHA.108.788166CrossRef
[5] Neuhauser HK, Adler C, Rosario AS, Diederichs C, Ellert U. Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008-11. J Hum Hypertens 2015;29(4):247 − 53. http://dx.doi.org/10.1038/jhh.2014.82CrossRef
[6] Guessous I, Bochud M, Theler JM, Gaspoz JM, Pechère-Bertschi A. 1999-2009 Trends in prevalence, unawareness, treatment and control of hypertension in Geneva, Switzerland. PLoS One 2012;7(6):e39877. http://dx.doi.org/10.1371/journal.pone.0039877CrossRef
[7] Satoh A, Arima H, Ohkubo T, Nishi N, Okuda N, Ae R, et al. Associations of socioeconomic status with prevalence, awareness, treatment, and control of hypertension in a general Japanese population: NIPPON DATA2010. J Hypertens 2017;35(2):401 − 8. http://dx.doi.org/10.1097/HJH.0000000000001169CrossRef
[8] Kang SH, Kim SH, Cho JH, Yoon CH, Hwang SS, Lee HY, et al. Prevalence, awareness, treatment, and control of hypertension in Korea. Sci Rep 2019;9:10970. http://dx.doi.org/10.1038/s41598-019-46965-4CrossRef
[9] Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;387(10022):957 − 67. http://dx.doi.org/10.1016/S0140-6736(15)01225-8CrossRef
[10] Vellakkal S, Millett C, Basu S, Khan Z, Selmi AA, Stuckler D, et al. Are estimates of socioeconomic inequalities in chronic disease artefactually narrowed by self-reported measures of prevalence in low-income and middle-income countries? Findings from the WHO-SAGE survey. J Epidemiol Community Health 2015;69(3):218 − 25. http://dx.doi.org/10.1136/jech-2014-204621CrossRef
[11] Lucumi DI, Schulz AJ, Roux AVD, Grogan-Kaylor A. Income inequality and high blood pressure in Colombia: a multilevel analysis. Cad Saude Publica 2017;33(11):e00172316. http://dx.doi.org/10.1590/0102-311x00172316CrossRef
[12] Malekzadeh MM, Etemadi A, Kamangar F, Khademi H, Golozar A, Islami F, et al. Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J Hypertens 2013;31(7):1364 − 71. http://dx.doi.org/10.1097/HJH.0b013e3283613053CrossRef
[13] Gee ME, Bienek A, Campbell NRC, Bancej CM, Robitaille C, Kaczorowski J, et al. Prevalence of, and barriers to, preventive lifestyle behaviors in hypertension (from a national survey of Canadians with hypertension). Am J Cardiol 2012;109(4):570 − 5. http://dx.doi.org/10.1016/j.amjcard.2011.09.051CrossRef